Skip to main content
. 2020 Oct 15;13:3749–3759. doi: 10.2147/DMSO.S268916

Table 3.

Evaluation of Liver Fibrosis and Steatosis

MS (n=150) Controls (n=150) P value
CAP, dB/m 335.2± 51.2 255.56 ± 60.8 <0.0001
Steatosis stage
 S0 21 (14%) 95 (63%) <0.0001
 S1 11 (7%) 15 (10%) 0.35
 S2 11 (7%) 3 (2%) 0.03
 S3 107 (71%) 37 (25%) <0.0001
LSM, kPa 7.24 ± 3.25 6.52± 2.85 0.04
Fibrosis stage
 F0–1 87 (58%) 118 (79%) 0.0001
 F2 28 (19%) 11 (7%) 0.002
 F3 20 (13%) 14 (9%) 0.26
 F4 15 (10%) 8 (5%) 0.10

Notes: Data are expressed as mean ± SD or number (percentage). Statistically significant values are shown in bold (P<0.05).

Abbreviations: CAP, controlled attenuation parameter; LSM, liver stiffness measurements; S, steatosis; F, fibrosis.